{"id":"NCT04535986","sponsor":"Verona Pharma plc","briefTitle":"A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD","officialTitle":"A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-29","primaryCompletion":"2022-09-12","completion":"2022-12-02","firstPosted":"2020-09-02","resultsPosted":"2023-11-13","lastUpdate":"2023-11-13"},"enrollment":763,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Ensifentrine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of ensifentrine in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"Least Square (LS) Mean Change From Baseline in Average Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over 12 Hours (AUC0-12h) at Week 12","timeFrame":"Baseline (pre-dose on Day 1) and Week 12","effectByArm":[{"arm":"Ensifentrine","deltaMin":0.0611,"sd":0.01825},{"arm":"Placebo","deltaMin":-0.0256,"sd":0.0195}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":122,"countries":["United States","Bulgaria","Czechia","Germany","Greece","Hungary","Poland","Romania","Russia","Slovakia","South Korea","United Kingdom"]},"refs":{"pmids":["39854278","39197510","39106052","37364283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":477},"commonTop":["Nasopharyngitis","Headache","COVID-19","Upper respiratory tract infection","Hypertension"]}}